| A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. (NCT00783549) | GlaxoSmithKline | 2008-09-04 |
| Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer (NCT03055143) | Sun Pharma Advanced Research Company Limited | 2008-09-03 |
| Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation (NCT04247230) | Futura Medical Developments Ltd. | 2008-09-03 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors (NCT00788125) | City of Hope Medical Center | 2008-09-03 |
| A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) (NCT00768521) | Merck Sharp & Dohme LLC | 2008-09-03 |
| Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion (NCT00791271) | M.D. Anderson Cancer Center | 2008-09-02 |
| Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma (NCT00753168) | Othera Pharmaceuticals | 2008-09-01 |
| Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol (NCT00768274) | Resverlogix Corp | 2008-09-01 |
| Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition (NCT01627886) | Dr. Reddy's Laboratories Limited | 2008-09-01 |
| A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers (NCT00776841) | Galmed Medical Reserch | 2008-09-01 |
| Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions (NCT01714856) | Lupin Ltd. | 2008-09-01 |
| Phenylephrine Pediatric Pharmacokinetic Study (NCT00762567) | Johnson & Johnson Consumer and Personal Products Worldwide | 2008-09-01 |
| Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP) (NCT00744042) | Alexion Pharmaceuticals, Inc. | 2008-09-01 |
| Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating (NCT01671800) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2008-09-01 |
| MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028) (NCT00768170) | Merck Sharp & Dohme LLC | 2008-09-01 |
| PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma (NCT00686842) | AIDS Malignancy Consortium | 2008-09-01 |
| A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors (NCT00724100) | Albany Molecular Research, Inc. | 2008-09-01 |
| A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects (NCT00856570) | Astellas Pharma Inc | 2008-09-01 |
| A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease (NCT00760981) | David Miklos | 2008-09-01 |
| Pharmacodynamic Characterization of Dienogest (NCT00754871) | Bayer | 2008-09-01 |
| Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction (NCT00738517) | University Medicine Greifswald | 2008-09-01 |
| Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration (NCT00712491) | Santen Inc. | 2008-09-01 |
| Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions (NCT01717235) | Lupin Ltd. | 2008-09-01 |
| To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin (NCT00768105) | AstraZeneca | 2008-09-01 |
| Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks (NCT00743015) | Boehringer Ingelheim | 2008-09-01 |
| Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects (NCT00565929) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) (NCT00760734) | Paul G. Harch, M.D. | 2008-09-01 |
| A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies (NCT00761696) | Infinity Pharmaceuticals, Inc. | 2008-09-01 |
| Efficacy Study of Kinesio Taping to Treat Muscular and Joint Problems in Chronic Venous Insufficiency (NCT01501188) | Universidad de Granada | 2008-09-01 |
| MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors (NCT02444884) | Children's Oncology Group | 2008-09-01 |
| A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650) (NCT00767793) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM) (NCT00750815) | H. Lee Moffitt Cancer Center and Research Institute | 2008-09-01 |
| PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection (NCT00775424) | University of Pennsylvania | 2008-09-01 |
| Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM) (NCT00989547) | Technical University of Munich | 2008-09-01 |
| A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer (NCT01240720) | Philogen S.p.A. | 2008-09-01 |
| A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer (NCT00748553) | University of Utah | 2008-09-01 |
| Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. (NCT00761982) | Hospital Universitario Central de Asturias | 2008-09-01 |
| A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT00753480) | Genentech, Inc. | 2008-09-01 |
| A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors (NCT00682279) | GlaxoSmithKline | 2008-09-01 |
| METHOD (Minimally Invasive, Endoscopically-delivered, Tolerable by Human Individuals, Non-morbid Obesity Device) Study (NCT00753350) | Sensate LLC | 2008-09-01 |
| "Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study" (Citrugrêle) (NCT00756080) | Nantes University Hospital | 2008-09-01 |
| Multiple-Dose Study of VGX-1027 in Healthy Subjects (NCT00760396) | VGX Pharmaceuticals, LLC | 2008-09-01 |
| A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848 (NCT00743860) | GlaxoSmithKline | 2008-09-01 |
| Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects (NCT00721474) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-09-01 |
| A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) (NCT00746317) | Chugai Pharmaceutical | 2008-09-01 |
| Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project (NCT00742664) | University of South Florida | 2008-09-01 |
| Absorption, Distribution, Metabolism and Excretion of [14C]- Labeled BIA 5-453 and Metabolites (NCT03014375) | Bial - Portela C S.A. | 2008-09-01 |
| Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016 (NCT00739232) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-09-01 |
| Melatonin Osteoporosis Prevention Study (NCT01152580) | Duquesne University | 2008-09-01 |
| Drug-Drug Interaction Between Colchicine and Verapamil ER (NCT00983242) | Mutual Pharmaceutical Company, Inc. | 2008-09-01 |
| Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine (NCT00734175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-09-01 |
| A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice (NCT00984009) | Mutual Pharmaceutical Company, Inc. | 2008-09-01 |
| Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male Volunteers (NCT02261129) | Boehringer Ingelheim | 2008-09-01 |
| A Randomised Controlled Trial (RCT) to Evaluate Use of an Individual Auditory Cueing Device's (IACD's) on Freezing and Gait in People With Parkinson's Disease (PD) (NCT00727467) | University of Dublin, Trinity College | 2008-09-01 |
| Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer (NCT00693095) | John Sampson | 2008-09-01 |
| Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma (NCT00807196) | Maisonneuve-Rosemont Hospital | 2008-09-01 |
| Transcranial Magnetic Stimulation to Treat Parkinson's Disease (NCT00753519) | Mark Hallett | 2008-09-01 |
| Civamide Patch Safety, Tolerability and PK Study (NCT00758433) | Winston Laboratories | 2008-09-01 |
| A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers (NCT00755638) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2008-09-01 |
| Botulinum Toxin Injection Efficiency (NCT01041157) | Jyväskylä Central Hospital | 2008-09-01 |
| A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD). (NCT00760565) | Hoffmann-La Roche | 2008-09-01 |
| Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly People (NCT00696514) | Wageningen University | 2008-09-01 |
| Targeted Lower Extremity Joint Training (NCT00765544) | US Department of Veterans Affairs | 2008-09-01 |
| Folate Absorption Across the Large Intestine (NCT00941174) | The Hospital for Sick Children | 2008-09-01 |
| Single Dose Pharmacokinetics of Egalet® Oxycodone (NCT00801788) | Egalet Ltd | 2008-09-01 |
| Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers (NCT00752141) | Watson Pharmaceuticals | 2008-09-01 |
| Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848 (NCT00770003) | AstraZeneca | 2008-09-01 |
| Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers (NCT00765427) | QLT Inc. | 2008-09-01 |
| A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178 (NCT01663961) | Astellas Pharma Europe B.V. | 2008-09-01 |
| P300 Brain Computer Interface Keyboard to Operate Assistive Technology (NCT00860951) | University of Michigan | 2008-09-01 |
| Pilot Study of the Modified Atkins Diet for Tourette Syndrome (NCT00952601) | Johns Hopkins University | 2008-09-01 |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study (NCT00704600) | Maastricht Radiation Oncology | 2008-09-01 |
| A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas (NCT00768339) | Aegera Therapeutics | 2008-09-01 |
| First Time in Human Study of Protexia (NCT00744146) | PharmAthene, Inc. | 2008-09-01 |
| A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL (NCT00772486) | Memgen, LLC | 2008-09-01 |
| A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer (NCT00670553) | Novartis Pharmaceuticals | 2008-09-01 |
| Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments (NCT00749021) | Clement K. Chan | 2008-09-01 |
| Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors (NCT00787982) | Visualase, Inc. | 2008-09-01 |
| S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00937417) | SWOG Cancer Research Network | 2008-09-01 |
| Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer (NCT00882973) | Samyang Biopharmaceuticals Corporation | 2008-09-01 |
| A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment (NCT00750620) | Astellas Pharma Inc | 2008-09-01 |
| A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED) (NCT00757939) | Merck Sharp & Dohme LLC | 2008-09-01 |
| The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids (NCT00812370) | Children's Hospital Los Angeles | 2008-09-01 |
| Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E (NCT00761501) | AstraZeneca | 2008-09-01 |
| 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma (NCT00798148) | Tehran University of Medical Sciences | 2008-09-01 |
| Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers (NCT00754715) | AstraZeneca | 2008-09-01 |
| Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant (NCT00737113) | Mitchell Horwitz, MD | 2008-09-01 |
| A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors (NCT00747734) | Genentech, Inc. | 2008-09-01 |
| Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy (NCT00707655) | Genmab | 2008-09-01 |
| Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer (NCT00761345) | Fox Chase Cancer Center | 2008-09-01 |
| A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors (NCT00756912) | Eisai Inc. | 2008-09-01 |
| Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers (NCT00778388) | Valneva Austria GmbH | 2008-09-01 |
| Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236 (NCT00767052) | AstraZeneca | 2008-09-01 |
| Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide (NCT02169895) | Bial - Portela C S.A. | 2008-09-01 |
| Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes (NCT01147770) | Universitair Ziekenhuis Brussel | 2008-09-01 |
| Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia (NCT00660036) | University of Pittsburgh | 2008-09-01 |
| A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread (NCT01648764) | Eli Lilly and Company | 2008-09-01 |
| Matching Genotypes and Serotonergic Medications for Alcoholism (NCT01113164) | Brown University | 2008-09-01 |
| Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers (NCT02215772) | Boehringer Ingelheim | 2008-09-01 |
| Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU (NCT00747721) | Orion Corporation, Orion Pharma | 2008-09-01 |